Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Filed Mar 11, 2013 · 10-K · 70 days after period end · 0001062822-13-000008
| Metric | Q4 2011 | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|---|
| Revenue | $218.00K | $343.00K | — |
| Net Income | -$24.87M | -$33.85M | — |
| EPS Diluted | -$0.05 | -$0.10 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 11, 2013 · 70 d after period end
